ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00215202
Brief Title: Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

First Submitted : September 15, 2005
First Submitted that Met QC Criteria : September 15, 2005
First Posted : September 22, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : May 16, 2018
Last Update Posted : May 17, 2018